200 related articles for article (PubMed ID: 35443437)
1. Role of Rituximab in Patients with Resistant Nephrotic Syndrome.
Singh S; Agarwal D; Gupta R; Malhotra V; Bhardwaj S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443437
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
3. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
4. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
5. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
Bomback AS; Tumlin JA; Baranski J; Bourdeau JE; Besarab A; Appel AS; Radhakrishnan J; Appel GB
Drug Des Devel Ther; 2011 Mar; 5():147-53. PubMed ID: 21448451
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study.
Ma X; Fang L; Sheng L; Zhou X; Bai S; Zang X; Wang Y; Li M; Lv Z; Zhong Q; Yang X; Wang Y; Hu Y; Yan D; Shi Y; Chen H; Li J; Tao M; Zhuang S; Wang Y; Liu N
Ren Fail; 2023 Dec; 45(1):2237124. PubMed ID: 37482915
[TBL] [Abstract][Full Text] [Related]
11. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
[TBL] [Abstract][Full Text] [Related]
12. Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Podestà MA; Trillini M; Portalupi V; Gennarini A; Tomatis F; Villa A; Perna A; Rubis N; Remuzzi G; Ruggenenti P
Am J Kidney Dis; 2024 Mar; 83(3):340-349.e1. PubMed ID: 37777061
[TBL] [Abstract][Full Text] [Related]
13. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for the treatment of idiopathic membranous nephropathy with nephrotic syndrome: a systematic review and meta-analysis.
You L; Ye P; Xiao G; Liang J; Kong Y
Turk J Med Sci; 2021 Dec; 51(6):2870-2880. PubMed ID: 34391323
[TBL] [Abstract][Full Text] [Related]
16. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
[TBL] [Abstract][Full Text] [Related]
17. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[TBL] [Abstract][Full Text] [Related]
19. Therapy of Rituximab in Idiopathic Membranous Nephropathy with Nephrotic Syndrome: A Systematic Review and Meta-analysis.
Zou PM; Li H; Cai JF; Chen ZJ; Li C; Li XW
Chin Med Sci J; 2018 Mar; 33(1):9-19. PubMed ID: 29620510
[TBL] [Abstract][Full Text] [Related]
20. Rituximab therapy in nephrotic syndrome: implications for patients' management.
Sinha A; Bagga A
Nat Rev Nephrol; 2013 Mar; 9(3):154-69. PubMed ID: 23338210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
